Takeda shareholders group say working to block $62 billion Shire deal

TOKYO (Reuters) – A group of Takeda Pharmaceutical Co Ltd shareholders is building support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday.

Powered by WPeMatico

Scroll to top